A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the Elderly

Wing, Lindon M.H., Reid, Christopher M., Ryan, Philip, Beilin, Lawrence J., Brown, Mark A., Jennings, Garry L.R., Johnston, Colin I., McNeil, John J. +4 more·2003·New England Journal of Medicine

DOI 10.1056/nejmoa021716

Cited by (1,000)

Items 201–300 of 1,000

Effects of Losartan in Women With Hypertension and Left Ventricular Hypertrophy
Ingrid Os, Verónica Franco, Sverre Erik Kjeldsen, Karin Manhem, Richard B. Devereux, Eva Gerdts, Darcy A. Hille, Paulette A. Lyle, Peter M. Okin, Björn Dahlöf et al. · 2008 · Hypertension
Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Chirag Bavishi, Sripal Bangalore, Franz H. Messerli · 2016 · Progress in Cardiovascular Diseases
The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis
Paula T. Einhorn, Barry R. Davis, Barry M. Massie, William C. Cushman, Linda B. Piller, Lara M. Simpson, Daniel A Levy, Chuke Nwachuku, Henry R. Black · 2006 · American Heart Journal
Thiazide diuretics, endothelial function, and vascular oxidative stress
Ming-Sheng Zhou, Ivonne Hernandez Schulman, Edgar A. Jaimes, Leopoldo R. Raij · 2008 · Journal of Hypertension
Treatment of chronic kidney disease in older populations
Seiji Kishi, Hiroyuki Kadoya, Naoki Kashihara · 2024 · Nature Reviews Nephrology
Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies
Guang Hao, Zengwu Wang, Rui Guo, Zuo Chen, Xin Wang, Linfeng Zhang, Wei Li · 2014 · BMC Cardiovascular Disorders
Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice
Rachel Ann Elliott, Łukasz Tanajewski, Georgios Gkountouras, Anthony John Avery, Nick Barber, Rajnikant Laxmishanker Mehta, Matthew Boyd, Asam Latif, Antony Chuter, Justin J. Waring · 2017 · PharmacoEconomics
Sex and Gender Differences in Cardiovascular Drug Therapy
Ute Seeland, Vera Regitz‐Zagrosek · 2012 · Handbook of experimental pharmacology
Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure
Xiongjing Jiang, Michael F. O’Rourke, Yuqing Zhang, Xinye He, Lisheng Liu · 2007 · Journal of Hypertension
Review of blood pressure control rates and outcomes
George L. Bakris, Pantelis A. Sarafidis, Rajiv Agarwal, Luis Miguel Ruilope · 2013 · Journal of the American Society of Hypertension
Metabolic syndrome in the elderly
Matthew L. Bechtold, John C. Palmer, Joshua Valtos, Catherine Iasiello, James R. Sowers · 2006 · Current Diabetes Reports
Have ALLHAT, ANBP2, ASCOT-BPLA, and So Forth Improved Our Knowledge About Better Hypertension Care?
Peter T. Sawicki, Natalie McGauran · 2006 · Hypertension
Evidence-based medicine in hypertension: what type of evidence?
Alberto Zanchetti · 2005 · Journal of Hypertension
Morbus Diureticus in the Elderly: Epidemic Overuse of a Widely Applied Group of Drugs
Martin Wehling · 2013 · Journal of the American Medical Directors Association
Renin-Angiotensin-Aldosterone System Blockade Effects on the Kidney in the Elderly
Faruk Hilmi Turgut, Rasheed Abiodun Balogun, Emaad M. Abdel‐Rahman · 2010 · Clinical Journal of the American Society of Nephrology
Prescription of antihypertensive agents to haemodialysis patients: time trends and associations with patient characteristics, country and survival in the DOPPS
A. A. Lopes, Jennifer L. Bragg‐Gresham, Sylvia Ramirez, Vittorio Emanuele Andreucci, Takato Akiba, Akira Saitō, Stefan H. Jacobson, Bruce M. Robinson, F. K. Port, Nancy A. Mason et al. · 2009 · Nephrology Dialysis Transplantation
Reporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacy
Doreen M. Rabi, Nadia A. Khan, Michel Vallée, Michelle Hladunewich, Sheldon W. Tobe, Louise Pilote · 2008 · Canadian Journal of Cardiology
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
Sverre Erik Kjeldsen, Jan Stålhammar, Pål Hasvold, Johan Bodegård, Urban Olsson, David Russell · 2009 · Journal of Human Hypertension
Intraoperative arterial blood pressure lability is associated with improved 30 day survival
Matthew A. Levin, Gregory W. Fischer, Hung‐Mo Lin, Patrick J. McCormick, M. Krol, David L. Reich · 2015 · British Journal of Anaesthesia
Antihypertensive therapy and new onset diabetes
Franz H. Messerli, Ehud Grossman, Gastone Leonetti · 2004 · Journal of Hypertension
Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
Sverre Erik Kjeldsen, Stevo Julius · 2004 · American Heart Journal
Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass
Joel M. Neutel · 2003 · American Journal of Hypertension
Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths
Linton R. Harriss, Andrew Edward Ajani, David U. Hunt, James A. Shaw, B.R. Chambers, Helen Margaret Dewey, Judith H. Frayne, Alison Beauchamp, Karen Duvé, Graham G. Giles et al. · 2011 · Australian and New Zealand Journal of Public Health
Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)
W.J. Elliott · 2006 · Yearbook of Cardiology
Role of the renin–angiotensin system in the endocrine pancreas: Implications for the development of diabetes
Chris Tikellis, Mark E. Cooper, Merlin C. Thomas · 2005 · The International Journal of Biochemistry & Cell Biology
Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics
Charalambos Koumaras, Maria Tzimou, Eirini Stavrinou, Theodora Griva, Thomas D Gossios, Niki Katsiki, Vasilios Gabriel Athyros, Dimitri P. Mikhailidis, Asterios I. Karagiannis · 2012 · American Journal of Cardiovascular Drugs
BRITISH HYPERTENSION SOCIETY GUIDELINES Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
Bryan Williams, Neil R Poulter, MJ Brown, Mark R. Davis, P S Sever · 2004
Treating Hypertension — What Are We to Believe?
Edward David Frohlich · 2003 · New England Journal of Medicine
Half a Century of Hydrochlorothiazide: Facts, Fads, Fiction, and Follies
Franz H. Messerli, Sripal Bangalore · 2011 · The American Journal of Medicine
Similar Effects of Treatment on Central and Brachial Blood Pressures in Older Hypertensive Subjects in the Second Australian National Blood Pressure Trial
Anthony Michael Dart, James D. Cameron, Christoph D. Gatzka, Kristyn J. Willson, Yu‐Lu Liang, Karen L. Berry, Lindon M H Wing, Christopher Michael Reid, Philip Ryan, Lawrence Joseph Beilin et al. · 2007 · Hypertension
The Effect of Age on Hypertension Control and Management
Ann M. Borzecki, Mark E. Glickman, Boris Kader, Dan R. Berlowitz · 2006 · American Journal of Hypertension
Blood Pressure Reduction Is Not the Only Determinant of Outcome
Peter Sever, Neil R Poulter · 2006 · Circulation
β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients
Hong Ji Song, Joongyub Lee, Ye-Jee Kim, Sun‐Young Jung, Hwa Jung Kim, Nam‐Kyong Choi, Byung‐Joo Park · 2012 · Bone
Characterization of the Cardiac Renin Angiotensin System in Oophorectomized and Estrogen-Replete mRen2.Lewis Rats
Hao Wang, Jewell A. Jessup, Zhuo Zhao, Jaqueline Soares da Silva, Marina Lin, Lindsay M. MacNamara, Sarfaraz Ahmad, Mark C. Chappell, Carlos Maria Ferrario, Leanne Groban · 2013 · PLoS ONE
Are There Effects of Renin–Angiotensin System Antagonists Beyond Blood Pressure Control?
George L. Bakris · 2009 · The American Journal of Cardiology
Safety and efficacy of the oral direct renin inhibitor aliskiren in elderly patients with hypertension
Paolo Verdecchia, Carlos Calvo, Volker Möckel, Lucy Keeling, Andrew Satlin · 2007 · Blood Pressure
Gender Aspects in Cardiovascular Pharmacology
Sabine Oertelt‐Prigione, Vera Regitz‐Zagrosek · 2009 · Journal of Cardiovascular Translational Research
Do angiotensin II receptor blockers increase the risk of myocardial infarction?
Paolo Verdecchia, Fabio Angeli, Roberto Gattobigio, Gianpaolo Reboldi · 2005 · European Heart Journal
Diuretic Treatment of Hypertension
Ehud Grossman, Paolo Verdecchia, Ari Shamiss, Fabio Angeli, Gianpaolo Reboldi · 2011 · Diabetes Care
The Timing Hypothesis and Hormone Replacement Therapy: A Paradigm Shift in the Primary Prevention of Coronary Heart Disease in Women. Part 1: Comparison of Therapeutic Efficacy
Howard Neil Hodis, Wendy Jean Mack · 2013 · Journal of the American Geriatrics Society
Is it Time for a Cardiovascular Primary Prevention Trial in the Elderly?
Jennifer G. Robinson, George L. Bakris, James Torner, Neil J. Stone, Robert B. Wallace · 2006 · Stroke
Hypertensive Therapy: Part I
Verónica Franco, Suzanne Oparil, Oscar A. Carretero · 2004 · Circulation
Possible pathophysiologic mechanisms supporting the superior stroke protection of angiotensin receptor blockers compared to angiotensin-converting enzyme inhibitors: clinical and experimental evidence
Steven G. Chrysant · 2005 · Journal of Human Hypertension
Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
Azmil H. Abdul‐Rahim, Ana-Cristina Perez, Rachael L. Macisaac, Pardeep S. Jhund, Brian Lee Claggett, Peter E. Carson, Michel Komajda N, Robert Samuel McKelvie, Michael R. Zile, Karl B Swedberg et al. · 2016 · European Heart Journal
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP‐Hypertension‐2
Tord Ekbom, Erland Linjer, Thomas Hedner, Jan Lanke, Ulf dé Fairé, Per Olof Wester, Björn Dahlöf, Bengt Scherstén · 2004 · Blood Pressure
Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study
Joel M. Neutel, David H.G. Smith, Michael A. Weber, Lesley Schofield, Das Purkayastha, Marjorie R. Gatlin · 2005 · Journal of Clinical Hypertension
The role of renin–angiotensin– aldosterone system inhibition in chronic kidney disease
Keith C. Norris, Charles Vaughn · 2003 · Expert Review of Cardiovascular Therapy
Verapamil-sustained release–based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: An INternational VErapamil SR-Trandolapril (INVEST) substudy
Sripal Bangalore, Franz H. Messerli, Jerome D. Cohen, Peter H. Bacher, Peter Sleight, Giuseppe Mancia, Peter Russell Kowey, Qian Zhou, Annette Champion, Carl J. Pepine · 2008 · American Heart Journal
Renewed Interest in Chlorthalidone: Evidence From the Veterans Health Administration
Michael E. Ernst, Brian C. Lund · 2010 · Journal of Clinical Hypertension
Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition
Faiez M. Zannad, Wendy Gattis Stough, Bertram Pitt, John G.F. Cleland, Kirkwood F. Adams, Nancy L. Geller, Christian Tobias Torp-Pedersen, Bridget‐Anne Kirwan, Ferenc Folláth · 2008 · European Heart Journal
Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients
Joel M. Neutel · 2008 · Current Medical Research and Opinion
Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research
Kalipso Chalkidou, Andrew R. Hoy, Peter Littlejohns · 2007 · Journal of the Royal Society of Medicine
Hypertension and Diabetes: Role of the Renin-Angiotensin System
Karin Agnes Maria Jandeleit-Dahm, Mark Emmanuel Cooper · 2006 · Endocrinology and Metabolism Clinics of North America
Use of Ordinal Outcomes in Vascular Prevention Trials
Philip M. Bath, Chamila M. Geeganage, Laura J. Gray, Timothy John Collier, Stuart Pocock · 2008 · Stroke
Arterial hypertension in the female world
Christian Cadeddu Dessalvi, Flavia Franconi, Laura Cassisa, Ilaria Campesi, Alessia Pepe, Lucia Cugusi, Silvia Maffei, Sabina Gallina, Susanna Sciomer, Giuseppe Mercuro · 2016 · Journal of Cardiovascular Medicine
Central Blood Pressure as an Index of Antihypertensive Control: Determinants and Potential Value
Luc Trudeau · 2014 · Canadian Journal of Cardiology
Cardioprotective Effect of Thiazide-Like Diuretics: A Meta-Analysis
Chen Peng, Sandip Chaugai, Fujie Zhao, Dao Wen Wang · 2015 · American Journal of Hypertension
What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations
Debbie L. Cohen, Matthew G. Denker · 2013 · Clinical Interventions in Aging
Statins for Primary Prevention of Cardiovascular Mortality in Women: A Systematic Review and Meta-Analysis
Radhika Nandur Bukkapatnam, Nicole B. Gabler, William R. Lewis · 2009 · Preventive Cardiology
The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review
Roberto Ferrari, Eric H. Boersma · 2013 · Expert Review of Cardiovascular Therapy
Longing for clinical excellence
Alberto Zanchetti, Giuseppe Mancia · 2012 · Journal of Hypertension
Thiazide-Type Diuretics and β-Adrenergic Blockers as First-Line Drug Treatments for Hypertension
Jeffrey A. Cutler, Barry R. Davis · 2008 · Circulation
The ONTARGET/TRANSCEND Trial Programme: baseline data
Peter Sleight · 2005 · Acta Diabetologica
A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting – rationale, design and baseline characteristics
Caroline Laurence, Angela Gialamas, Lisa Nicole Yelland, Tanya Bubner, Philip Ryan, Kristyn J. Willson, Briony Glastonbury, Janice Gill, Mark D. S. Shephard, Justin Beilby · 2008 · Trials
Visit-to-visit (long-term) and ambulatory (short-term) blood pressure variability to predict mortality in an elderly hypertensive population
E. Chowdhury, Lindon M H Wing, Garry Jennings, Lawrence Joseph Beilin, Christopher Michael Reid · 2017 · Journal of Hypertension
Comorbidities and Differential Diagnosis in Heart Failure with Preserved Ejection Fraction
Ross T. Campbell, John J.V. McMurray · 2014 · Heart Failure Clinics
Impact of gender on statin efficacy
Krista M. Dale, Craig Ian Coleman, Sachin A. Shah, Aarti Patel, Jeffrey Kluger, Charles Michael White · 2007 · Current Medical Research and Opinion
Heart Failure and its Treatment in Women
Vera Regitz‐Zagrosek, Elke Lehmkuhl · 2005 · Herz
Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium
George C. Roush, Michael E. Ernst, John B. Kostis, Shamima Yeasmin, Domenic A. Sica · 2015 · Journal of Hypertension
The Kidney, Hypertension, and Remaining Challenges
Nitin Khosla, Rigas Kalaitzidis, George L. Bakris · 2009 · Medical Clinics of North America
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Suzanne Oparil, Barry R. Davis, William C. Cushman, Charles E. Ford, Curt Daniel Furberg, Gabriel B. Habib, L. Julian Haywood, Karen L. Margolis, Jeffrey L. Probstfield, Paul Kieran Whelton et al. · 2013 · Hypertension
Large Artery Stiffness Is Not Related to Plasma Cholesterol in Older Subjects with Hypertension
Anthony Michael Dart, Christoph D. Gatzka, James D. Cameron, Bronwyn A. Kingwell, Yu‐Lu Liang, Karen L. Berry, Christopher Michael Reid, Garry Jennings · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
ALLHAT, or the Soft Science of the Secondary End Point
Franz H. Messerli · 2003 · Annals of Internal Medicine
Benefits and risks of antihypertensive medications in the elderly
Debra A. Butt, Paula Harvey · 2015 · Journal of Internal Medicine
Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly ( ASPREE ) study
Jessica E. Lockery, Taya Annabelle Collyer, Walter P. Abhayaratna, Sharyn M. Fitzgerald, John J. McNeil, Mark Raymond Nelson, Suzanne Gaye Orchard, Christopher Michael Reid, Nigel Stocks, Ruth E. Trevaks et al. · 2018 · The Medical Journal of Australia
2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations
Kwang‐Il Kim, Sang‐Hyun Ihm, Gheun‐Ho Kim, Hyeon Chang Kim, Ju Han Kim, Hae‐Young Lee, Jang Hoon Lee, Jong Moo Park, Sungha Park, Wook Bum Pyun et al. · 2019 · Clinical Hypertension
Hypertension and antihypertensive treatment of diabetic nephropathy
Eberhard Ritz, Ralf Dikow · 2006 · Nature Reviews Nephrology
Enfermedad renal crónica: Clasificación, identificación, manejo y complicaciones
Juan C Flores, Miriam Alvo, Hernán Borja, Jorge Morales, Jorge E. Vega, Carlos Zúñiga, Hans Müller, J.A. Munzenmayer · 2009 · Revista médica de Chile
Central Aortic Reservoir-Wave Analysis Improves Prediction of Cardiovascular Events in Elderly Hypertensives
Om Prakash Narayan, Justin E. Davies, Alun David Hughes, Anthony Michael Dart, Kim H. Parker, Christopher Michael Reid, James D. Cameron · 2014 · Hypertension
Antihypertensive agents, insulin sensitivity, and new-onset diabetes
Pantelis A. Sarafidis, Samy I. McFarlane, George L. Bakris · 2007 · Current Diabetes Reports
Effect of the Angiotensin Receptor Blocker Valsartan on Coronary Microvascular Flow Reserve in Moderately Hypertensive Patients with Stable Coronary Artery Disease
Takahiro Higuchi, C. Abletshauser, Stephan G. Nekolla, Markus Schwaiger, Frank Michael Bengel · 2007 · Microcirculation
Hypertension Management: Rationale for Triple Therapy Based on Mechanisms of Action
Joel M. Neutel, David H.G. Smith · 2012 · Cardiovascular Therapeutics
Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
Ban Liu, Yuliang Wang, Yangyang Zhang, Biao Yan · 2019 · Current Topics in Medicinal Chemistry
Preventing diabetes in patients with hypertension: one more reason to block the renin–angiotensin system
Mark Emmanuel Cooper, Chris Tikellis, Merlin C. Thomas · 2006 · Journal of Hypertension
Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species
Derek E. Doran, Daiana Weiss, Yong Zhang, Kathy K. Griendling, William Robert Taylor · 2007 · Atherosclerosis
Persistence of Mortality Reduction After the End of Randomized Therapy in Clinical Trials of Blood Pressure–Lowering Medications
William J. Kostis, Lutgarde Thijs, Tom Richart, John B. Kostis, Jan A. Staessen · 2010 · Hypertension
A Home Blood Pressure Monitoring Study Comparing the Antihypertensive Efficacy of Two Angiotensin II Receptor Antagonist Fixed Combinations
BOBRIE, G, DELONCA, J, MOULIN, C, GIACOMINO, A, POSTELVINAY, N, ASMAR, R · 2005 · American Journal of Hypertension
The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis
Atle Fretheim, Morten Aaserud, Andrew David Oxman · 2003 · BMC Health Services Research
RAAS inhibition and mortality in hypertension
Roberto Ferrari · 2013 · Global Cardiology Science and Practice
Pharmacological management of obesity an endocrine society clinical practice guideline
Caroline Margaret Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie Elizabeth McDonnell, Mohammad Hassan Murad, Uberto Pagotto, Donna H. Ryan, Christopher D. Still · 2015 · Reproductive Endocrinology
Smaller Aortic Dimensions Do Not Fully Account for the Greater Pulse Pressure in Elderly Female Hypertensives
Anthony Michael Dart, Bronwyn A. Kingwell, Christoph D. Gatzka, Kristyn J. Willson, Yu‐Lu Liang, Karen L. Berry, Lindon M H Wing, Christopher Michael Reid, Philip Ryan, Lawrence Joseph Beilin et al. · 2008 · Hypertension
Predictive accuracy and usefulness of calibration of the ESC SCORE in Switzerland
Pedro Manuel Marques-Vidal, Nicolas Rodondi, Murielle Bochud, Alain R. Pécoud, Daniel Hayoz, Fred Michel Paccaud, Vincent Mooser, Gérard Waeber, Péter Vollenweider · 2008 · European Journal of Cardiovascular Prevention & Rehabilitation
Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus
Darren K. McGuire, Jeffrey R. Winterfield, Jason Rytlewski, Ele Ferrannini · 2008 · Diabetes and Vascular Disease Research
Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke?
Florent Boutitie, Roxana Oprisiu, Jean Michel Achard, Hakim Mazouz, Ji‐Guang Wang, Franz H. Messerli, François Gueyffier, A. Fournier · 2007 · Journal of Hypertension
Drug Targets in the Voltage-Gated Calcium Channel Family: Why Some Are and Some Are Not
David J. Triggle · 2003 · Assay and Drug Development Technologies
Impact of a social marketing media campaign on public awareness of hypertension
Robert John Petrella, Mark R. Speechley, Peter W. Kleinstiver, Terrence David Ruddy · 2005 · American Journal of Hypertension
Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide—meta-analysis
Stela Dineva, Katya Hristova Uzunova, Velichka Pavlova, Elena Pavlova Filipova, Krassimir Kalinov, Toni Yonkov Vekov · 2019 · Journal of Human Hypertension
ACE Inhibitors and Angiotensin II Receptor Antagonists
Andreas Dendorfer, Peter Dominiak, Heribert Schunkert · 2005 · Handbook of experimental pharmacology
Endothelial dysfunction and hypertension in diabetes mellitus
Paresh Dandona, Ajay Chaudhuri, Ahmad Aljada · 2004 · Medical Clinics of North America
Impact of Diabetes on Left Ventricular Diastolic Function in Patients with Arterial Hypertension
Rolf Wachter, Claus Lüers, Sibylle Kleta, Kerstin Griebel, Christoph Herrmann‐Lingen, Lutz Binder, Nico Janicke, Dirk Wetzel, Michael M. Kochen, Burkert Mathias Pieske · 2007 · European Journal of Heart Failure